Announcements Trials

Browse Landscape

Status

Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 2 Tuberous Sclerosis 1 Smoking 1 Neoplasms 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphangioleiomyomatosis 1 Lip Neoplasms 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Endocrine Gland Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Phlebotomy × Clear all

NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Endocrine Gland Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡